Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Short Interest Update

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) saw a large increase in short interest in September. As of September 30th, there was short interest totaling 722,200 shares, an increase of 47.9% from the September 15th total of 488,200 shares. Based on an average daily volume of 421,800 shares, the short-interest ratio is presently 1.7 days. Based on an average daily volume of 421,800 shares, the short-interest ratio is presently 1.7 days.

Hedge Funds Weigh In On Bioceres Crop Solutions

A number of hedge funds and other institutional investors have recently made changes to their positions in BIOX. Jones Financial Companies Lllp boosted its holdings in shares of Bioceres Crop Solutions by 3,535.8% in the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock worth $25,000 after buying an additional 5,339 shares during the last quarter. Bank of America Corp DE boosted its holdings in shares of Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock worth $35,000 after buying an additional 3,735 shares during the last quarter. PDT Partners LLC purchased a new position in shares of Bioceres Crop Solutions in the 1st quarter worth about $81,000. Avanza Fonder AB lifted its holdings in Bioceres Crop Solutions by 62.9% during the second quarter. Avanza Fonder AB now owns 26,164 shares of the company’s stock valued at $117,000 after purchasing an additional 10,099 shares during the last quarter. Finally, Walleye Capital LLC purchased a new stake in Bioceres Crop Solutions during the first quarter valued at about $199,000. 17.68% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

BIOX has been the topic of several recent research reports. Canaccord Genuity Group reiterated a “hold” rating and set a $2.50 target price (down from $6.50) on shares of Bioceres Crop Solutions in a research report on Wednesday, September 10th. Wall Street Zen lowered shares of Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a report on Saturday, September 13th. Brookline Capital Management lowered shares of Bioceres Crop Solutions from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 21st. Weiss Ratings restated a “sell (d)” rating on shares of Bioceres Crop Solutions in a report on Wednesday, October 8th. Finally, Oppenheimer lowered shares of Bioceres Crop Solutions from an “outperform” rating to a “market perform” rating in a report on Wednesday. One equities research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $4.17.

Bioceres Crop Solutions Stock Performance

NASDAQ BIOX opened at $1.91 on Thursday. Bioceres Crop Solutions has a 1 year low of $1.20 and a 1 year high of $7.44. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.02 and a quick ratio of 0.74. The firm has a market cap of $119.78 million, a price-to-earnings ratio of -2.36 and a beta of 0.33. The company has a fifty day moving average price of $2.09 and a 200-day moving average price of $3.52.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.